LIFECORE BIOMEDICAL, INC. \DE\
LFCR · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Kiper Christopher S: Form 4
Insider disclosure · Filed · Report period 04 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- LFCR · 514766104 - Common Stock, $0.001 par value
Company details and SEC sources
CIK 0001005286 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- LFCR on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 3515 Lyman Boulevard, Chaska, MN, 55318
- Incorporated in
- DE
- Fiscal year end
- 25 May
- Former names on EDGAR
- LANDEC CORP \CA\ (to 07 Nov 2022)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields